Advertisement

Topics

FDA Approves New Indication and Formulation for Olaparib

12:55 EDT 17 Aug 2017 | Medscape

The FDA has now approved the use of olaparib tablets as maintenance therapy in recurrent ovarian cancer.
FDA Approvals

Original Article: FDA Approves New Indication and Formulation for Olaparib

NEXT ARTICLE

More From BioPortfolio on "FDA Approves New Indication and Formulation for Olaparib"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...